Skip to content

Clinical trials

Completed Cardiovascular Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Status: Completed Country / region: South Korea Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20062
20083
20095
20101
20113
20122
20131
20144
20154
20161
20171
20185
20195
20212
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Bundang Hospital6
GlaxoSmithKline4
Chong Kun Dang Pharmaceutical3
Seoul National University Hospital3
AstraZeneca2
Bayer2
Eli Lilly and Company2
Novartis Pharmaceuticals2
Seung-Jung Park2
Yonsei University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases44
Atherosclerosis7
Coronary Artery Disease7
Heart Diseases7
Myocardial Infarction6
Acute Coronary Syndrome5
Coronary Disease4
Hypertension4
Diabetes Mellitus, Type 23
Stroke3

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.